- Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trialsRaburn M Mallory
MedImmune, LLC, Gaithersburg, Maryland, United States of America
PLoS ONE 5:e13755. 2010..The safety, tolerability, and immunogenicity of a monovalent intranasal 2009 A/H1N1 live attenuated influenza vaccine (LAIV) were evaluated in children and adults...
- Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of ageRaburn M Mallory
MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA
Vaccine 29:4322-7. 2011..The incidence, duration, and other parameters of viral shedding after vaccination with LAIV have not been fully described in children ≤ 5 years of age...
- The role of nasal IgA in children vaccinated with live attenuated influenza vaccineChristopher S Ambrose
MedImmune, LLC, Gaithersburg, MD 20878, USA
Vaccine 30:6794-801. 2012..The role of IgA in providing protection against influenza in children vaccinated with live attenuated influenza vaccine (LAIV) has not been well described...